Boston Scientific Corp <BSX.N>: Citigroup cuts to neutral from buy; cuts target price to $50 from $57
BSX•Related News
TNS unit Waypoint launches Archon market data entitlement management system
XLF•
Global Net Lease declares USD 0.45 quarterly dividend on 7.25% Series A preferred stock
GNL•
Huntington Bancshares Inc. <HBAN.O>: Wells Fargo cuts target price to $21 from $23
HBAN•
Warner Bros. Discovery, Inc. <WBD.O>: Barclays reinstates coverage with equal weight rating; target price $29
WBD•
Tower Semi, NewPhotonics start high-volume shipments of laser-integrated optical engine PICs for AI interconnects
TSEM•